Schneider-Hohendorf, T;
Mohan, H;
Bien, CG;
Breuer, J;
Becker, A;
Görlich, D;
Kuhlmann, T;
... Schwab, N; + view all
(2016)
CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing.
Nature Communications
, 7
, Article 11153. 10.1038/ncomms11153.
Preview |
Text (Published article)
Schneider-Hohendorf_CD8+_T-cell_pathogenicity.pdf Download (1MB) | Preview |
Preview |
Text (Supplementary information)
Schneider-Hohendorf_CD8+_T-cell_pathogenicity_Suppl.pdf Download (324kB) | Preview |
Abstract
Rasmussen encephalitis (RE) is a rare paediatric epilepsy with uni-hemispheric inflammation and progressive neurological deficits. To elucidate RE immunopathology, we applied T-cell receptor (TCR) sequencing to blood (n=23), cerebrospinal fluid (n=2) and brain biopsies (n=5) of RE patients, and paediatric controls. RE patients present with peripheral CD8(+) T-cell expansion and its strength correlates with disease severity. In addition, RE is the only paediatric epilepsy with prominent T-cell expansions in the CNS. Consistently, common clones are shared between RE patients, who also share MHC-I alleles. Public RE clones share Vβ genes and length of the CDR3. Rituximab/natalizumab/basiliximab treatment does not change TCR diversity, stem cell transplantation replaces the TCR repertoire with minimal overlap between donor and recipient, as observed in individual cases. Our study supports the hypothesis of an antigen-specific attack of peripherally expanded CD8(+) lymphocytes against CNS structures in RE, which might be ameliorated by restricting access to the CNS.
Type: | Article |
---|---|
Title: | CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/ncomms11153 |
Publisher version: | http://dx.doi.org/10.1038/ncomms11153 |
Language: | English |
Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
Keywords: | Antibodies, Monoclonal, CD8-Positive T-Lymphocytes, Central Nervous System, Encephalitis, Humans, Molecular Sequence Data, Natalizumab, Receptors, Antigen, T-Cell, Recombinant Fusion Proteins, Rituximab, Sequence Analysis, Protein |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept |
URI: | https://discovery.ucl.ac.uk/id/eprint/1553694 |
Archive Staff Only
![]() |
View Item |